Hikma Pharmaceuticals Plc Block listing Interim Review (3133V)
13 Aprile 2021 - 12:35PM
UK Regulatory
TIDMHIK
RNS Number : 3133V
Hikma Pharmaceuticals Plc
13 April 2021
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 13 April 2021
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
-------------------------------------------------------------
Period of return From: 1 October 2020 To: 31 March 2021
------------------------------- ------ --------------------
Balance of unallotted securities under scheme(s) from SOP: 792,700 Ordinary Shares of 10 pence
previous return:
-------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been SOP: 0 Ordinary Shares of 10 pence
increased since the date of the last
return (if any increase has been applied for):
-------------------------------------------------------------
Less: Number of securities issued/allotted under SOP: 0 Ordinary Shares of 10 pence
scheme(s) during period (see LR3.5.7G):
-------------------------------------------------------------
Equals: Balance under scheme(s) not yet SOP: 792,700 Ordinary Shares of 10 pence
issued/allotted at end of period:
-------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 13 April 2021
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
---------------------------------------------------------------------
Period of return From: 1 October 2020 To: 31 March 2021
------------------------------------ ------ -----------------------
Balance of unallotted securities under LTIP: 57,502 Ordinary Shares of 10 pence
scheme(s) from previous return:
---------------------------------------------------------------------
Plus: The amount by which the block scheme(s) LTIP: 0 Ordinary Shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
---------------------------------------------------------------------
Less: Number of securities issued/allotted LTIP: 0 Ordinary Shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
---------------------------------------------------------------------
Equals: Balance under scheme(s) not yet LTIP: 57,502 Ordinary Shares of 10 pence
issued/allotted at end of period:
---------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 13 April 2021
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")
--------------------------------------------------------------------------
Period of return From: 1 October 2020 To: 31 March 2021
-------------------------------------- ------- -------------------------
Balance of unallotted securities under 2009 MIP: 139,696 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------------
Plus: The amount by which the block 2009 MIP: 0 Ordinary Shares of 10 pence
scheme(s) has been increased since the
date of the last
return (if any increase has been applied
for):
--------------------------------------------------------------------------
Less: Number of securities 2009 MIP: 3,514 Ordinary Shares of 10 pence
issued/allotted under scheme(s) during
period (see LR3.5.7G):
--------------------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2009 MIP: 136,182 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 13 April 2021
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP")
--------------------------------------------------------------------------
Period of return From: 1 October 2020 To: 31 March 2021
-------------------------------------- ------- -------------------------
Balance of unallotted securities under 2018 MIP: 1,000,000 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------------
Plus: The amount by which the block 2018 MIP: 0 Ordinary Shares of 10 pence
scheme(s) has been increased since the
date of the last
return (if any increase has been applied
for):
--------------------------------------------------------------------------
Less: Number of securities 2018 MIP: 0 Ordinary Shares of 10 pence
issued/allotted under scheme(s) during
period (see LR3.5.7G):
--------------------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2018 MIP: 1,000,000 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 13 April 2021
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
--------------------------------------------------------------------
Period of return From: 1 October 2020 To: 31 March 2021
----------------------------------- ------- ----------------------
Balance of unallotted securities under EIP: 512,424 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------
Plus: The amount by which the block scheme(s) EIP: 1,000,000 Ordinary Shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------------
Less: Number of securities issued/allotted EIP: 272,457 Ordinary Shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
--------------------------------------------------------------------
Equals: Balance under scheme(s) not yet EIP: 1,239,967 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRGPUUWCUPGGUW
(END) Dow Jones Newswires
April 13, 2021 06:35 ET (10:35 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024
